ANN ARBOR, MI--(MARKET WIRE)--Aug 13, 2007 -- Pipex Pharmaceuticals, Inc. (AMEX:PP - News), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today its results and achievements for the three and six month periods ended June 30, 2007.
